Clinical characteristics and risk factors of acute lymphoblastic leukemia in children with severe infection during maintenance treatment

被引:1
|
作者
Yin, Tiantian [1 ]
Han, Juan [1 ]
Hao, Jinjin [1 ]
Yu, Hui [1 ]
Qiu, Yining [1 ]
Xu, Jiawei [1 ]
Peng, Yun [1 ]
Wu, Xiaoyan [1 ]
Jin, Runming [1 ]
Zhou, Fen [1 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Pediat, Wuhan 430022, Peoples R China
来源
CANCER MEDICINE | 2023年 / 12卷 / 19期
关键词
acute lymphoblastic leukemia; children; maintenance phase; risk factors; severe infection; GRANULOCYTE TRANSFUSIONS; PEDIATRIC-PATIENTS; INDUCTION THERAPY; CANCER; PNEUMONIA; COMPLICATIONS;
D O I
10.1002/cam4.6495
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Infection is the most common adverse event of acute lymphoblastic leukemia (ALL) treatment and is also one of the main causes of death.Methods: To investigate the clinical characteristics and risk factors of severe infections during the maintenance phase of ALL treatment, we conducted a retrospective study.Results: A total of 181 children were eligible and 46 patients (25.4%) suffered from 51 events of severe infection, most of which occurred in the first half year of the maintenance phase (52.9%). The most common infection was pulmonary infection (86.3%) followed by bloodstream infection (19.6%). The main symptoms of ALL patients with pulmonary infection were fever, cough, and shortness of breath. The main manifestations of computer tomography (CT) were ground glass shadow (56.8%), consolidation shadow (27.3%), and streak shadow (25%). Multivariate binary logistic regression analysis showed that agranulocytosis, agranulocytosis >= 7 days, anemia, and low globulin level were independent risk factors for severe infection during the maintenance phase (all p < 0.05).Conclusions: Taken together, blood routine examinations and protein levels should be monitored regularly for ALL patients in the maintenance phase, especially in the first 6 months. For ALL patients with risk factors, preventive anti-infective or supportive therapies can be given as appropriate to reduce the occurrence of severe infections.
引用
收藏
页码:19372 / 19382
页数:11
相关论文
共 50 条
  • [31] Risk Factors and the Prevention of Weight Gain During Induction Chemotherapy in Children With Acute Lymphoblastic Leukemia
    Belle, Fabien N.
    Kasteler, Rahel
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2018, 40 (08) : 630 - 630
  • [32] Assessment of Bone Mineral Density and Risk Factors in Children Completing Treatment for Acute Lymphoblastic Leukemia
    Gunes, Adalet Meral
    Can, Erkan
    Saglam, Halil
    Ilcol, Yesim Ozarda
    Baytan, Birol
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2010, 32 (03) : E102 - E107
  • [33] EVALUATION OF LIVER PERFORMANCE DURING MAINTENANCE MANAGEMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN
    MANCINI, AF
    ROSITO, P
    VECCHI, V
    VIVARELLI, F
    FALDELLA, G
    DELUCA, M
    MINERVA PEDIATRICA, 1977, 29 (36) : 2133 - 2142
  • [34] Cytomegalovirus Retinitis in Children with Acute Lymphoblastic Leukemia During Maintenance Phase Chemotherapy
    Rahman, A. A.
    Begum, F.
    Begum, M.
    Kibria, C. S. H.
    Islam, A.
    Jamal, C. Y.
    Noor, S. Fateha
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S186 - S187
  • [35] Immune reconstitution during maintenance therapy in children with acute lymphoblastic leukemia, relation to co-existing infection
    El-Chennawi, Farha A.
    Al-Tonbary, Youssef A.
    Mossad, Youssef M.
    Ahmed, Mona A.
    HEMATOLOGY, 2008, 13 (04) : 203 - 209
  • [36] Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia
    Liu, Chengcheng
    Yang, Wenjian
    Devidas, Meenakshi
    Cheng, Cheng
    Pei, Deqing
    Smith, Colton
    Carroll, William L.
    Raetz, Elizabeth A.
    Bowman, W. Paul
    Larsen, Eric C.
    Maloney, Kelly W.
    Martin, Paul L.
    Mattano, Leonard A., Jr.
    Winick, Naomi J.
    Mardis, Elaine R.
    Fulton, Robert S.
    Bhojwani, Deepa
    Howard, Scott C.
    Jeha, Sima
    Pui, Ching-Hon
    Hunger, Stephen P.
    Evans, William E.
    Loh, Mignon L.
    Relling, Mary V.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (18) : 2133 - +
  • [37] Clinical and Germline Risk Factors for the Occurrence of Multiple Treatment Toxicities during Childhood Acute Lymphoblastic Leukemia (ALL) Therapy
    Mateos, Marion K.
    Trahair, Toby N.
    Mayoh, Chelsea
    Barbaro, Pasquale M.
    George, Carly
    Sutton, Rosemary
    Revesz, Tamas
    Barbaric, Draga
    Giles, Jodie
    Alvaro, Frank
    Mechinaud, Francoise Marie
    Catchpoole, Daniel R.
    Kotecha, Rishi Sury
    Quinn, Michael C. J.
    Chenevix-Trench, Georgia
    MacGregor, Stuart
    Dalla-Pozza, Luciano
    Marshall, Glenn M.
    BLOOD, 2017, 130
  • [38] CLOTTING ABNORMALITIES IN CHILDREN DURING MAINTENANCE CHEMOTHERAPY FOR ACUTE LYMPHOBLASTIC-LEUKEMIA
    ARICO, M
    GAMBA, G
    RAITERI, E
    MONTANI, N
    DEAMICI, M
    BURGIO, GR
    HAEMATOLOGICA, 1991, 76 (06) : 472 - 474
  • [39] Port-A-Catheter Infection Rate and Associated Risk Factors in Children Diagnosed with Acute Lymphoblastic Leukemia
    Portilho Junqueira, Beatriz Lasmar
    Connolly, Bairbre
    Abla, Oussama
    Tomlinson, George A.
    Pires Vieira Amaral, Joao Guilherme
    BLOOD, 2009, 114 (22) : 410 - 410
  • [40] Risk Factors associated to survival in children and adolescent with Acute Lymphoblastic Leukemia
    Jimenez de Samudio, Angelica
    Samudio, Margarita
    Caniza, Miguela A.
    PEDIATRIA-ASUNCION, 2016, 43 (01): : 18 - 26